+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Exosome Diagnostic and Therapeutic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Application; Product; End User, and Country

  • ID: 5147208
  • Report
  • August 2020
  • Region: Europe
  • 93 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cell Guidance Systems
  • Evomic Science LLC
  • Exosome Diagnostics
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • Reneuron Group Plc
  • MORE
The Europe exosome diagnostic and therapeutic market is projected to reach US$ 12,524.24 thousand in 2019 to US$ 104,694.72 thousand by 2027. This represents a CAGR of 31.7% from 2020 to 2027.

The growth of the exosome diagnostic and therapeutic market is primarily attributed to greater precision, advantages over traditional methods of diagnosis and therapeutics, and rise in R&D activities.

Exosome is an emerging industry with a huge potential. Applications of exosomes are expanding rapidly in the areas of disease diagnosis and treatment as well as pharmaceuticals. Exosomes are nanovesicles and act as a vehicle to deliver therapies to cells of the body. In the future, exosomes can be used as potential biomarkers and in the field of personalized medicine. Interest in exosome research has increased dramatically in recent years, driving the growth of the exosome diagnostic and therapeutic market in the UK. New exosome therapeutics companies are rapidly entering the marketplace. The investment flow has also increased to support such innovative therapeutic companies, further boosting the growth of the market. For example, in 2016, ReNeuron Group plc, a leading UK-based stem cell therapy development company, was awarded about US$ 2.6 million grant from Innovate UK to advance its emerging exosome nanomedicine platform.

In terms of application, the diagnostics application segment accounted for a larger share of the Europe exosome diagnostic and therapeutic market. Its growth is attributed to an increasing adoption of exosome-based instruments and kits for diagnosis of chronic conditions. Additionally, exosome-based diagnostic products offer benefits such as accuracy, lower processing time, and better ergonomics; these are likely to drive the growth of diagnostic application segment in the Europe exosome diagnostic and therapeutic market
In 2019, the instrument segment held a considerable share of the for exosome diagnostic and therapeutic market, by the product. This segment is also predicted to dominate the market by 2027 owing to higher demand for diagnostics instruments. However, the software segment is anticipated to witness growth at a significant rate during the forecast period.

A few major primary and secondary sources for the exosome diagnostic and therapeutic market included in the report are Instrument, US Food and Drug Administration, and World Health Organization, among others.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cell Guidance Systems
  • Evomic Science LLC
  • Exosome Diagnostics
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • Reneuron Group Plc
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Europe Exosome diagnostic and therapeutic Market - By Application
1.3.2 Europe Exosome diagnostic and therapeutic Market - By Product
1.3.3 Europe Exosome diagnostic and therapeutic Market - By End User
1.3.4 Europe Exosome Diagnostic and Therapeutic Market - By Country

2. Exosome Diagnostic And Therapeutic Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Exosome Diagnostic and Therapeutic Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 Europe- PEST Analysis

5. Europe Exosome Diagnostic and Therapeutic Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis

6. Exosome Diagnostic and Therapeutic Market Analysis - By Application
6.1 Overview
6.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
6.3 Diagnostic
6.3.1 Overview
6.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
6.4 Therapeutic
6.4.1 Overview
6.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)

7. Exosome Diagnostic and Therapeutic Market Analysis By Product
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
7.5 Software
7.5.1 Overview
7.5.2 Software: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

8. Exosome Diagnostic and Therapeutic Market Analysis By End User
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
8.3 Cancer Institutes
8.3.1 Overview
8.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.5 Diagnostic Centres
8.5.1 Overview
8.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.6 Other End User
8.6.1 Overview
8.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

9. Exosome Diagnostic and Therapeutic Market - Country Analysis
9.1 Europe: Exosome Diagnostic and Therapeutic Market
9.1.1 Overview
9.1.2 Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.3 Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
9.1.4 Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.5 Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
9.1.6 Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
9.1.7 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.7.1 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.8 Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
9.1.9 Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.10 Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
9.1.11 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.12 France: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
9.1.13 France: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.14 France: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
9.1.15 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.15.1 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.16 UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
9.1.17 UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.18 UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
9.1.19 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.19.1 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.20 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
9.1.21 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.22 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
9.1.23 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.23.1 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
9.1.24 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
9.1.25 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
9.1.26 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)

10. IMPACT OF COVID-19 PANDEMIC ON EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
10.1 Europe: Impact assessment of COVID-19 Pandemic

11. COMPANY PROFILES
11.1 Cell Guidance Systems
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Evomic Science LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Norgen Biotek Corp
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Miltenyi Biotec
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 RENEURON GROUP PLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ITH, Immune Therapy Holdings AB
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 EXOSOME DIAGNOSTICS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

List of Tables
Table 1. Europe Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)
Table 2. Europe Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 3. Europe Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 4. Germany Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 5. Germany Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 6. Germany Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 7. France Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 8. France Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 9. France Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 10. UK Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 11. UK Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 12. UK Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Italy Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 14. Italy Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Italy Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Spain Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 17. Spain Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 18. Spain Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 19. Glossary of Terms, Exosome diagnostic and treatment market

List of Figures
Figure 1. Exosome Diagnostic and Therapeutic Market Segmentation
Figure 2. Exosome Diagnostic and Therapeutic Segmentation, By Region
Figure 3. Europe Exosome Diagnostic and Therapeutic Market Overview
Figure 4. Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market
Figure 5. Germany Is Expected to Show Remarkable Growth during the Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Exosome diagnostic and therapeutic market impact analysis of driver and restraints
Figure 8. Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
Figure 9. Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 10. Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 11. Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)
Figure 12. Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 15. Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)
Figure 16. Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 19. Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Europe: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)
Figure 21. Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
Figure 22. Germany: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 23. France: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 24. UK: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 25. Italy: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Spain: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. IMPACT OF COVID-19 PANDEMIC IN EUROPE COUNTRY MARKETS
Note: Product cover images may vary from those shown
  • Cell Guidance Systems
  • Evomic Science LLC
  • Exosome Diagnostics
  • ITH, Immune Therapy Holdings AB
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • Reneuron Group Plc
Note: Product cover images may vary from those shown
Adroll
adroll